BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16844528)

  • 1. Nodular mastocytosis.
    Kasprowicz S; Chan IJ; Wall DJ; Tharp MD
    J Am Acad Dermatol; 2006 Aug; 55(2):347-9. PubMed ID: 16844528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-kit Asp-816-Val mutation analysis in patients with mastocytosis.
    Verzijl A; Heide R; Oranje AP; van Schaik RH
    Dermatology; 2007; 214(1):15-20. PubMed ID: 17191042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cutaneous mastocytosis].
    Flageul B
    Rev Prat; 2006 Oct; 56(16):1745-51. PubMed ID: 17315498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-kit Mutations in patients with childhood-onset mastocytosis and genotype-phenotype correlation.
    Yanagihori H; Oyama N; Nakamura K; Kaneko F
    J Mol Diagn; 2005 May; 7(2):252-7. PubMed ID: 15858149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letter: Cutaneous mastocytosis with systemic involvement mimicking clinical and dermatoscopically multiple melanocytic nevi.
    Gutiérrez-González E; Ginarte M; Toribio J
    Dermatol Online J; 2011 Nov; 17(11):15. PubMed ID: 22136871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KIT masters mast cells in kids, too.
    Kambe N; Longley BJ; Miyachi Y; Kabashima K
    J Invest Dermatol; 2010 Mar; 130(3):648-50. PubMed ID: 20145643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel, activating KIT-N822I mutation in familial cutaneous mastocytosis.
    Wasag B; Niedoszytko M; Piskorz A; Lange M; Renke J; Jassem E; Biernat W; Debiec-Rychter M; Limon J
    Exp Hematol; 2011 Aug; 39(8):859-65.e2. PubMed ID: 21689725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal onset diffuse cutaneous mastocytosis: a case report and review of the literature.
    Koga H; Kokubo T; Akaishi M; Iida K; Korematsu S
    Pediatr Dermatol; 2011; 28(5):542-6. PubMed ID: 20678092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum of mast cell activation disorders.
    Petra AI; Panagiotidou S; Stewart JM; Conti P; Theoharides TC
    Expert Rev Clin Immunol; 2014 Jun; 10(6):729-39. PubMed ID: 24784142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A c-kit mutation in exon 18 in familial mastocytosis.
    Wöhrl S; Moritz KB; Bracher A; Fischer G; Stingl G; Loewe R
    J Invest Dermatol; 2013 Mar; 133(3):839-841. PubMed ID: 23190889
    [No Abstract]   [Full Text] [Related]  

  • 12. A case of childhood-onset cutaneous mastocytosis with loss of wild-type KIT allele.
    Hida T; Okura M; Kamiya T; Yamamoto M; Hori T; Uhara H
    J Eur Acad Dermatol Venereol; 2019 Jun; 33(6):e235-e237. PubMed ID: 30773694
    [No Abstract]   [Full Text] [Related]  

  • 13. N822K c-kit mutation in CD30-positive cutaneous pleomorphic mastocytosis after germ cell tumour of the ovary.
    Baek JO; Kang HK; Na SY; Lee JR; Roh JY; Lee JH; Kim HJ; Park S
    Br J Dermatol; 2012 Jun; 166(6):1370-3. PubMed ID: 22233328
    [No Abstract]   [Full Text] [Related]  

  • 14. Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations.
    Bodemer C; Hermine O; Palmérini F; Yang Y; Grandpeix-Guyodo C; Leventhal PS; Hadj-Rabia S; Nasca L; Georgin-Lavialle S; Cohen-Akenine A; Launay JM; Barete S; Feger F; Arock M; Catteau B; Sans B; Stalder JF; Skowron F; Thomas L; Lorette G; Plantin P; Bordigoni P; Lortholary O; de Prost Y; Moussy A; Sobol H; Dubreuil P
    J Invest Dermatol; 2010 Mar; 130(3):804-15. PubMed ID: 19865100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-KIT-Positive Fatal Diffuse Cutaneous Mastocytosis With Systemic Manifestations in a Neonate.
    Chaudhary N; Shapiro N; Bhutada A; Rastogi S
    J Pediatr Hematol Oncol; 2019 Jul; 41(5):e338-e340. PubMed ID: 30067557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Occult" mastocytosis with activating c-kit point mutation evolving into systemic mastocytosis associated with plasma cell myeloma and secondary amyloidosis.
    Sotlar K; Saeger W; Stellmacher F; Stahmer J; Jäckle S; Valent P; Horny HP
    J Clin Pathol; 2006 Aug; 59(8):875-8. PubMed ID: 16873565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation analysis of C-KIT in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis.
    Fritsche-Polanz R; Jordan JH; Feix A; Sperr WR; Sunder-Plassmann G; Valent P; Födinger M
    Br J Haematol; 2001 May; 113(2):357-64. PubMed ID: 11380399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD1a-positive familial cutaneous mastocytosis without germ-line or somatic mutations in c-kit.
    Arase N; Wataya-Kaneda M; Oiso N; Arase H; Katayama I
    Br J Dermatol; 2013 Jul; 169(1):201-4. PubMed ID: 23834123
    [No Abstract]   [Full Text] [Related]  

  • 19. Telangiectasia macularis eruptiva perstans, a form of cutaneous mastocytosis, associated with malignant melanoma.
    Kowalzic L; Eickenscheidt L; Seidel C; Kribus S; Ziegler H; Komar M
    J Dtsch Dermatol Ges; 2009 Apr; 7(4):360-2. PubMed ID: 19054427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bullous mastocytosis: report of a patient and a brief review of the literature.
    Avshalumov K; Pichardo R; Jorizzo JL; Sangueza OP; Goldenberg G
    Am J Dermatopathol; 2008 Oct; 30(5):455-7. PubMed ID: 18806488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.